1. In patients with previously treated metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), treatment with sacituzumab...
1. In this randomized controlled trial, mepolizumab decreased the annualized rate of moderate or severe exacerbations when added to triple...
1. The risk of tuberculosis (TB) was higher in individuals with obstructive or restrictive lung function impairment compared to those...
1. In this cohort of patients with a pulmonary embolism (PE), ultrasound catheter-directed thrombolysis (USAT) is safe for symptomatic patients...
1. Patients in the ivonescimab group demonstrated a significantly greater progression-free survival than those in the pembrolizumab group. 2. Grade...
1. Standalone motivational interviewing post-discharge did not reduce rehospitalization in older multimorbid patients with heart failure or chronic obstructive pulmonary...
1. Aspiration pneumonia in post-stroke patients showed significantly increased 90-day mortality, longer hospital stays, and more cardiovascular events at one...
1. Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to...
1. In this randomized, placebo-controlled replicate trial, depemokimab decreased the annual rate of exacerbations among patients with severe eosinophilic asthma....
1. The use of high flow nasal cannula (HFNC) in patients with obesity undergoing sedated gastrointestinal endoscopy significantly reduced the...
